SANDRA A. GARDINER
CIK 1218574 · CFO & EVP Admin. and Finance · last filed 2025-03-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
15
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADGM | Director | — | $0.45 | — | $0 | 1 | 2025-03-21 |
| Lucira Health, Inc. (LHDX) Delisted | Director | — | $0.45 | — | $0 | 1 | 2022-06-03 |
| PLSE | CFO & EVP Admin. and Finance | — | $35.47 | — | $0 | 3 | 2022-02-28 |
| CUTERA INC (CUTR) Delisted | EVP & Chief Financial Officer | 31,161 | $0.10 | $3.0K | $0 | 6 | 2019-02-14 |
| Aspira Women's Health Inc. (VRML) Delisted | VP & Chief Financial Officer | 24,000 | — | — | $0 | 2 | 2011-03-22 |
| LIPID SCIENCES INC/ (LIPD) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2007-12-05 |
Recent Filings · Page 2 of 2
15 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-19 | CUTERA INC (CUTR) Delisted | Grant (A) | +7,157 | $0 | EDGAR |
| 2011-03-22 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +24,000 | $0 | EDGAR |
| 2010-05-26 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-05 | LIPID SCIENCES INC/ (LIPD) Delisted | Mixed | — | $0 | EDGAR |
| 2007-02-05 | LIPID SCIENCES INC/ (LIPD) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.